A2A Pharmaceuticals Inc. named Dr. Sotirios G. Stergiopoulos as president and CEO.
Here is a look at BioSpace’s top 10 stories of 2018.
Swiss biotechnology company Molecular Partners could earn more than $500 million in payments after striking a deal with U.S. drug giant Amgen to work together in cancer immunotherapy.
Richard Klinghoffer, Ph.D., was named CEO of Presage Biosciences.
James (Jim) Robinson is named president and CEO of Alkermes Inc. Robinson joined Alkermes from Astellas US LLC, where he served as president, Americas Operations with responsibility for the company’s operations in North and South America. Alkermes is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) […]
R&D success and M&A activity loom as large swing factors for the bio sector in 2017 with the regulatory arena potentially at its most amenable for years.
This chart shows the 2016 and 2015 revenue and R&D figures for some of the world’s leading biotech and biopharma companies.
Jean-Marie Cuillerot, M.D., has been appointed chief medical officer of Agenus Inc. Dr. Cuillerot initially joined Agenus in 2016 as VP and Global Head of Clinical Development.
David A. Spiegel, M.D., Ph.D., is now CEO of Kleo Pharmaceuticals Inc.